Home » Health » Maternal Diabetes Linked to Lower Type 1 Diabetes Risk in Children

Maternal Diabetes Linked to Lower Type 1 Diabetes Risk in Children

by Dr. Michael Lee – Health Editor

Research Highlights Protective Epigenetic Effects of Maternal Type 1 Diabetes on Offspring

Recent research from Helmholtz Munich has revealed​ a potential protective effect of maternal type 1 diabetes (T1D) against the advancement of islet​ autoimmunity in children.A study, published in Nature metabolism (Ott et al., 2025, DOI: 10.1038/s42255-025-01403-w), identified ‍specific DNA methylation patterns – epigenetic modifications – in children exposed to maternal T1D that correlate with ​a reduced risk of developing islet autoimmunity.

Researchers found that children with‌ islet autoimmunity ‍exhibited significantly ​lower scores related to these protective epigenetic signatures, suggesting a link between these modifications and⁢ protection against the disease. the findings‌ indicate that environmental factors, specifically maternal T1D, can influence risk through epigenetic changes at key T1D risk genes.

Building on this discovery, a follow-up project led by ​Prof.Sandra Hummel, and supported by a $550,000 ‍grant ‌from the Leona M. and ⁢Harry B. Helmsley Charitable Trust, aims to delve deeper into the ‌mechanisms behind this protective effect. the research ⁢team, collaborating with Prof. Ezio Bonifacio and colleagues from⁢ the Center for regenerative therapies Dresden at the Technical University of Dresden, will investigate which‍ T1D risk genes are⁤ epigenetically influenced by​ maternal diabetes. They⁤ will also explore whether similar ⁢epigenetic effects are observed in children of mothers with gestational diabetes.

The project will also investigate potential protein and metabolome⁢ biomarkers associated with DNA ⁢methylation​ patterns,and how these molecular‌ changes contribute‌ to ‍protection ⁤against islet ‍autoimmunity. Researchers will analyze ⁤biosamples from​ the GPPAD ‌studies, the BABYDIAB ​and BABYDIÄT cohorts, and the Fr1da study.

The research is being‌ conducted⁣ by Dr. Raffael Ott and Prof. Sandra Hummel at the Institute for​ Diabetes Research, Helmholtz Munich. Helmholtz ⁤Munich, a leading biomedical⁣ research center with approximately ​2,500 employees, focuses on environmentally caused diseases, including diabetes, obesity, allergies, and chronic lung diseases, with the goal of developing groundbreaking‌ solutions for a healthier society. It⁢ is a member of the Helmholtz Association, Germany’s ‍largest scientific association.

Source: Ott et al., 2025: Blood methylome‍ signatures in children exposed to ⁣maternal type‌ 1 ⁢diabetes are linked to protection against islet autoimmunity.⁢ Nature Metabolism. DOI: 10.1038/s42255-025-01403-w. https://www.nature.com/articles/s42255-025-01403-w

Last‍ edited: 07.11.2025

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.